Organization · Venture Capital
Spencer Trask & Co.
Spencer Trask & Co. is a venture development firm based in Greenwich, Connecticut, focusing on advanced technology sectors such as healthcare, genomics, and artificial intelligence. The firm has a legacy of supporting transformative ventures, co-founding or funding twelve startups that achieved valuations exceeding $1 billion.
Overview
What Spencer Trask & Co. does
What Spencer Trask & Co. is
Spencer Trask & Co. is a venture development firm based in Greenwich, Connecticut, focusing on advanced technology sectors such as healthcare, genomics, and artificial intelligence. The firm has a legacy of supporting transformative ventures, co-founding or funding twelve startups that achieved valuations exceeding $1 billion.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1881
- Approximate age
- About 145 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find Spencer Trask & Co. elsewhere
Open the official website or a supported primary organization account.
Capability profile
Spencer Trask & Co. as a funder
Investment thesis
Spencer Trask & Co. focuses on transformative technology that enhances human potential, investing in sectors such as genomics, healthcare, AI, and legal tech. They operate as a venture development firm, co-founding and building companies with long time horizons.
Focus narrative
Spencer Trask & Co. invests in technology companies with the potential for significant societal impact. Their focus spans sectors including healthcare, biotechnology, communications, and artificial intelligence. The organization supports ventures at various stages, from conception to market launch, with a thesis centered on improving global well-being.
Value beyond capital
Spencer Trask & Co. adds value by not only providing capital but also co-founding and building companies, leveraging their extensive industry experience and networks to support portfolio companies in achieving their growth potential.
Focus and fit
- Stages
- Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo
- Regions
- Global · North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 12
- Recorded notable exits
- Fastcase
Portfolio context
Notable portfolio companies include Myriad Genetics, a leader in genomics diagnostics; Health Dialog, which commercializes evidence-based medicine; and Fastcase, an AI-driven legal research platform that recently merged with vLex. Other ventures include DFMsim Inc., known for AI solutions in semiconductor manufacturing, and Ultra Capital LLC, focused on sustainable infrastructure.
Common questions
What to know about Spencer Trask & Co.
Upseed classifies Spencer Trask & Co. under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.